An improved Pythium insidiosum-vaccine formulation with enhanced immunotherapeutic properties in horses and dogs with pythiosis

Mendoza, 1996, Infections caused by the oomycetous pathogen Pythium insidiosum, J. Mycol. Med., 6, 151

Mendoza L. Pythium insidiosum. In: Ajello L, Hay RJ, editors. Topley and Wilson’s microbiology and microbial infections. Medical mycology, vol. 4. London: Arnold; 1998. p. 617–30.

Eaton, 1993, Osseous involvement by Pythium insidiosum, Compendium, 15, 485

Mendoza, 1988, Bone lesions caused by Pythium insidiosum in a horse, J. Med. Vet. Mycol., 26, 5, 10.1080/02681218880000021

Alfaro, 1990, Four cases of equine bone lesions caused by Pythium insidiosum, Equine Vet. J., 22, 295, 10.1111/j.2042-3306.1990.tb04273.x

Goad, 1984, Pulmonary pythiosis in a horse, Vet. Pathol., 21, 261, 10.1177/030098588402100224

Cock de, 1987, Pythium insidiosum sp. nov. the etiologic agent of pythiosis, J. Clin. Microbiol., 25, 344, 10.1128/JCM.25.2.344-349.1987

Shenep, 1998, Successful medical therapy for deeply invasive facial infection due to Pythium insidiosum in a child, Clin. Infect. Dis., 27, 1388, 10.1086/515042

Chaffin, 1995, Cutaneous pythiosis in the horse, Vet. Clin. North Am. Equine Pract., 11, 91, 10.1016/S0749-0739(17)30334-6

Thomas, 1998, Pythiosis in dogs and cats, Compendium, 20, 63

Newton, 1993, Equine pythiosis: an overview of immunotherapy, Compendium, 15, 491

Miller, 1981, Treatment of equine phycomycosis by immunotherapy and surgery, Aust. Vet. J., 67, 377, 10.1111/j.1751-0813.1981.tb00526.x

Mendoza, 1992, Evaluation of two vaccines for the treatment of pythiosis insidiosi in horses, Mycopathologia, 119, 89, 10.1007/BF00443939

Dixon, 1998, Development of vaccines and their use in prevention of fungal infections, Med. Mycol., 36, 57

Thitithanyanont, 1998, The use of an immunotherapeutic vaccine to treat a life threatening human ateritis infection caused by Pythium insidiosum, Clin. Infect. Dis., 27, 1394, 10.1086/515043

Mendoza, 1986, Immunodiffusion test for diagnosing and monitoring pythiosis in horses, J. Clin. Microbiol., 23, 813, 10.1128/JCM.23.5.813-816.1986

Mendoza, 1997, Serodiagnosis of Pythium insidiosum infections using an enzyme-linked immunosorbent assay, Clin. Diagn. Lab. Immunol., 4, 715, 10.1128/CDLI.4.6.715-718.1997

Mendoza, 1987, Antigenic relationship between the animal and human pathogen Pythium insidiosum and nonpathogenic Pythium species, J. Clin. Microbiol., 25, 2159, 10.1128/JCM.25.11.2159-2162.1987

Julia, 1996, Resistance to Leishmania major induced by tolerance to a single antigen, Science, 274, 421, 10.1126/science.274.5286.421

Haberer, 1998, Leishmania pifanoi amastigote antigen P-4: epitops involved in T-cell responsiveness in human cutaneous leishmaniasis, Infect. Immun., 66, 3100, 10.1128/IAI.66.7.3100-3105.1998

Secrist, 1993, Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals, J. Exp. Med., 178, 2123, 10.1084/jem.178.6.2123

The Jordan Report. Accelerated development of vaccines. Bethesda (MD): Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institute of Health (NIH); 2002. p. 106.

Steidler, 2000, Treatment of murine colitis by Lactococcus lactis secreting interleukin-10, Science, 289, 1352, 10.1126/science.289.5483.1352

Convit, 1993, The clinical and immunological spectrum of American cutaneous leishmaniasis, Trans R. Soc. Trop. Med. Hyg., 87, 444, 10.1016/0035-9203(93)90030-T

Mendoza, 1993, Life cycle of the human and animal Oomycotic pathogen Pythium insidiosum, J. Clin. Microbiol., 31, 2967, 10.1128/JCM.31.11.2967-2973.1993